Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system

European Journal of Pharmacology

Volumn 672, Issue 1-3, 2011, Pages 106-112

  Zarrindast, Mohammad Reza ^a,b,c,d,e,f   Sroushi, Ailar ^a   Bananej, Maryam ^a   Vousooghi, Nasim ^b,c,g   Hamidkhaniha, Shokouh ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^f INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^g HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anxiety; Basolateral amygdala; Dopamine receptor; Elevated plus maze; Physostigmine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; PILOCARPINE; SCOPOLAMINE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ACETYLCHOLINE; AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; DOPAMINE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; MALE; MAZE LEARNING; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 81255161006     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.168     Document Type: Article

References (56)

1. G.D. Bartoszyk Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors Life Sci. 62 1998 649 663 (Pubitemid 28045572)
2. R.J. Blanchard, E.B. Yudko, R.J. Rodgers, and D.C. Blanchard Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety Behav. Brain Res. 58 1993 155 165 (Pubitemid 24024055)
3. M.L. Bouthenet, E. Souil, M.P. Martres, P. Sokoloff, B. Giros, and J.C. Schwartz Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA Brain Res. 564 1991 203 219
4. J.D. Brioni, A.B. O'Neill, D.J. Kim, and M.W. Decker Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test Eur. J. Pharmacol. 238 1993 1 8 (Pubitemid 23197854)
5. M. Davis, and P.J. Whalen The amygdala: vigilance and emotion Mol. Psychiatry 6 2001 13 34 (Pubitemid 32096061)
6. M.P. de la Mora, L. Cardenas-Cachon, M. Vazquez-Garcia, M. Crespo-Ramirez, K. Jacobsen, M. Hoistad, L. Agnati, and K. Fuxe Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat Neurosci. Lett. 377 2005 101 105 (Pubitemid 40312417)
7. M.P. de la Mora, A. Gallegos-Cari, Y. Arizmendi-Garcia, D. Marcellino, and K. Fuxe Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis Prog. Neurobiol. 90 2010 198 216
8. A.R. de Oliveira, A.E. Reimer, and M.L. Brandao Dopamine D2 receptor mechanisms in the expression of conditioned fear Pharmacol. Biochem. Behav. 84 2006 102 111 (Pubitemid 43975554)
9. A. Degroot, and D. Treit Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests Brain Res. 949 2002 60 70 (Pubitemid 35246177)
10. A. Degroot, S. Kashluba, and D. Treit Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests Pharmacol. Biochem. Behav. 69 2001 391 399 (Pubitemid 32758722)
11. E. Engin, and D. Treit The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1399 1419 (Pubitemid 352033664)
12. Q. Greba, A. Gifkins, and L. Kokkinidis Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle Brain Res. 899 2001 218 226 (Pubitemid 32324163)
13. F.A. Guarraci, R.J. Frohardt, and B.S. Kapp Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning Brain Res. 827 1999 28 40 (Pubitemid 29222901)
14. F.A. Guarraci, R.J. Frohardt, W.A. Falls, and B.S. Kapp The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning Behav. Neurosci. 114 2000 647 651 (Pubitemid 30490910)
15. S. Hecker, and M.M. Mesulam Two types of cholinergic projections to the rat amygdala Neuroscience 60 1994 383 397 (Pubitemid 24175210)
16. R.P. Hellendall, D.A. Godfrey, C.D. Ross, D.M. Armstrong, and J.L. Price The distribution of choline acetyltransferase in the rat amygdaloid complex and adjacent cortical areas, as determined by quantitative micro-assay and immunohistochemistry J. Comp. Neurol. 249 1986 486 498 (Pubitemid 16067236)
17. T. Inoue, T. Izumi, X.B. Li, Y. Kitaichi, S. Nakagawa, and T. Koyama Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear Eur. J. Pharmacol. 519 2005 253 258 (Pubitemid 41278546)
18. R.C. Klein, and J.L. Yakel Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex J. Physiol. 576 2006 865 872 (Pubitemid 44637889)
19. S. Kroner, J.A. Rosenkranz, A.A. Grace, and G. Barrionuevo Dopamine modulates excitability of basolateral amygdala neurons in vitro J. Neurophysiol. 93 2005 1598 1610 (Pubitemid 40283743)
20. R.T. Lalumiere, and J.L. McGaugh Memory enhancement induced by post-training intrabasolateral amygdala infusions of beta-adrenergic or muscarinic agonists requires activation of dopamine receptors: involvement of right, but not left, basolateral amygdala Learn. Mem. 12 2005 527 532 (Pubitemid 41397213)
21. R.T. Lalumiere, L.T. Nguyen, and J.L. McGaugh Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems Eur. J. Neurosci. 20 2004 2804 2810 (Pubitemid 39573795)
22. E.W. Lamont, and L. Kokkinidis Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm Brain Res. 795 1998 128 136 (Pubitemid 28337824)
23. J.E. LeDoux Emotional memory systems in the brain Behav. Brain Res. 58 1993 69 79
24. J.E. LeDoux, J. Iwata, P. Cicchetti, and D.J. Reis Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear J. Neurosci. 8 1988 2517 2529
25. A.I. Levey, S.M. Edmunds, C.J. Heilman, T.J. Desmond, and K.A. Frey Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain Neuroscience 63 1994 207 221 (Pubitemid 24333962)
26. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology (Berl) 92 1987 180 185 (Pubitemid 17072893)
27. D.C. Mash, and L.T. Potter Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain Neuroscience 19 1986 551 564 (Pubitemid 17022718)
28. A.J. McDonald, F. Mascagni, and L. Guo Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat Neuroscience 71 1996 55 75 (Pubitemid 26042870)
29. N. McNaughton, and P.J. Corr A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance Neurosci. Biobehav. Rev. 28 2004 285 305 (Pubitemid 38844377)
30. M.J. Millan The neurobiology and control of anxious states Prog. Neurobiol. 70 2003 83 244 (Pubitemid 37309295)
31. L. Nitecka, and Y. Ben-Ari Distribution of GABA-like immunoreactivity in the rat amygdaloid complex J. Comp. Neurol. 266 1987 45 55 (Pubitemid 18011388)
32. D. Pare, and Y. Smith Distribution of GABA immunoreactivity in the amygdaloid complex of the cat Neuroscience 57 1993 1061 1076 (Pubitemid 23355007)
33. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 4th ed. 1998 Academic Press New York
34. S. Pellow, and S.E. File Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat Pharmacol. Biochem. Behav. 24 1986 525 529 (Pubitemid 16145187)
35. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167 (Pubitemid 16239568)
36. M. Perez de la Mora, K.X. Jacobsen, M. Crespo-Ramirez, C. Flores-Gracia, and K. Fuxe Wiring and volume transmission in rat amygdala. Implications for fear and anxiety Neurochem. Res. 33 2008 1618 1633
37. F.L. Reis, S. Masson, A.R. de Oliveira, and M.L. Brandao Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests Pharmacol. Biochem. Behav. 79 2004 359 365 (Pubitemid 40029240)
38. A. Rezayof, S.S. Hosseini, and M.R. Zarrindast Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors Behav. Brain Res. 202 2009 171 178
39. A. Rezayof, L. Khajehpour, and M.R. Zarrindast The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors Neuroscience 160 2009 255 263
40. R.J. Rodgers, and J.C. Cole Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety Behav. Pharmacol. 6 1995 283 289
41. R.J. Rodgers, and N.J. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol. Biochem. Behav. 52 1995 297 303
42. R.J. Rodgers, E.M. Nikulina, and J.C. Cole Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze Pharmacol. Biochem. Behav. 49 1994 985 995 (Pubitemid 24376040)
43. L.M. Romanski, and J.E. LeDoux Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning J. Neurosci. 12 1992 4501 4509
44. J.A. Rosenkranz, and A.A. Grace Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo J. Neurosci. 19 1999 11027 11039 (Pubitemid 30235746)
45. S. Royer, M. Martina, and D. Pare An inhibitory interface gates impulse traffic between the input and output stations of the amygdala J. Neurosci. 19 1999 10575 10583 (Pubitemid 30228063)
46. R.J. Scibilia, J.E. Lachowicz, and C.D. Kilts Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain Synapse 11 1992 146 154
47. H. Sienkiewicz-Jarosz, A.I. Czlonkowska, M. Siemiatkowski, P. Maciejak, J. Szyndler, and A. Plaznik The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia J. Neural Transm. 107 2000 1403 1412 (Pubitemid 32049936)
48. H. Sienkiewicz-Jarosz, P. Maciejak, P. Krzascik, A.I. Czlonkowska, J. Szyndler, A. Bidzinski, W. Kostowski, and A. Plaznik The effects of central administration of physostigmine in two models of anxiety Pharmacol. Biochem. Behav. 75 2003 491 496 (Pubitemid 36859836)
49. P. Simon, C. Panissaud, and J. Costentin Sulpiride anxiogenic-like effect inhibition by a D1 dopamine receptor antagonist Neuroreport 3 1992 941 942
50. J.W. Smythe, D. Murphy, S. Bhatnagar, C. Timothy, and B. Costall Muscarinic antagonists are anxiogenic in rats tested in the black-white box Pharmacol. Biochem. Behav. 54 1996 57 63 (Pubitemid 26146663)
51. J.W. Smythe, S. Bhatnagar, D. Murphy, C. Timothy, and B. Costall The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test Brain Res. Bull. 45 1998 89 93 (Pubitemid 28048773)
52. D.G. Spencer Jr. , E. Horvath, and J. Traber Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections Brain Res. 380 1986 59 68 (Pubitemid 16011093)
53. E.A. van der Zee, and P.G. Luiten Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory Prog. Neurobiol. 58 1999 409 471 (Pubitemid 29249004)
54. Y. Watanabe, Y. Ikegaya, H. Saito, and K. Abe Roles of GABAA, NMDA and muscarinic receptors in induction of long-term potentiation in the medial and lateral amygdala in vitro Neurosci. Res. 21 1995 317 322
55. M.F. Weiner, D. Svetlik, and R.C. Risser What depressive symptoms are reported in Alzheimer's patients? Int. J. Geriatr. Psychiatry 12 1997 648 652 (Pubitemid 27290546)
56. M.R. Zarrindast, Z. Fattahi, P. Rostami, and A. Rezayof Role of the cholinergic system in the rat basolateral amygdala on morphine-induced conditioned place preference Pharmacol. Biochem. Behav. 82 2005 1 10 (Pubitemid 41423480)